Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience.

Leonardo CalzaVincenzo ColangeliGiulia PensalfineLucia AppolloniSalvatore VitaleIsabella BonPierluigi Viale

Published in: International journal of STD & AIDS (2023)

In our study, simplification to a single-tablet regimen of doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed PLWHIV was effective and showed a good tolerability profile, in association with a significant improvement in serum lipid levels.

Keyphrases

hiv infected patients
antiretroviral therapy
hiv infected
open label
randomized controlled trial
fatty acid
double blind